Skip to content

NBP

NovaBridge Biosciences

NASDAQ · Healthcare · Biotechnology · US

$1.62
−0.61%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 12, 2026
EPS estimate
-$0.08
Revenue estimate

Latest reported

Last report date
Aug 20, 2026
EPS actual
-$0.22
EPS estimate
-$0.01
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
3
EPS misses (12Q)
6
EPS in line (12Q)
0
Avg surprise (4Q)
-1056.0%
Revenue beats (12Q)
2
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 20, 2026-$0.01-$0.22Miss -2660.35%
Jun 29, 2026-$0.01-$0.11Miss -1280.18%
Dec 18, 2025-$0.06-$0.25Miss -316.67%
May 15, 2025-$0.06-$0.04Beat 33.33%
Nov 14, 2024-$0.16-$0.25Miss -56.25%
Aug 28, 2024-$0.51-$0.07Beat 86.27%
Apr 30, 2024-$0.26$564.0K
Mar 29, 2024-$0.10$0.02Beat 116.17%$164.2K
Aug 17, 2023-$0.26-$0.28Miss -7.23%$1.4M
May 1, 2023-$0.56$20.0M
Nov 10, 2022-$0.41$3.9M
Aug 30, 2022-$0.16-$0.54Miss -235.01%$19.1M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027